Subscribe to RSS
DOI: 10.1055/s-2002-32417
Georg Thieme Verlag Stuttgart · New York
Preeclampsia Associated With Antiphospholipid and Anti-β2-Glycoprotein-I Antibodies and Postpartum Thrombocytopenia, Cardiac Dysfunction, and Blindness: A Case Report
Präeklampsie bei gleichzeitigem Vorliegen von Antiphospholipid- und Anti-β2-Glykoprotein-I-Antikörpern und postpartaler Thrombozytopenie, Herzfunktionsstörung und Erblindung: Ein FallberichtPublication History
Publication Date:
24 June 2002 (online)
Zusammenfassung
Fallbericht über eine Patientin mit schwerer Präeklampsie und postpartalen Komplikationen, bei der eine Palette von Autoimmunreaktionen auftrat.
Fallbericht
Eine 27-jährige erstmals Schwangere wurde nach 37-wöchiger Schwangerschaft mit schwerer Präeklampsie eingewiesen. Es wurde ein Kaiserschnitt vorgenommen. Postpartal trat eine gravierende Herzfunktionsstörung auf, sowie eine Thrombozytopenie, Anfälle von Eklampsie und Erblindung. Immunohistochemische Plazenta-Untersuchungen ergaben eine deutliche Ablagerung von terminalem C5b-9 Komplementkomplex im intervillösen Fibrin und intervillösen Ovarialstroma.
Schlussfolgerung
An der Pathogenese der Präeklampsie-Eklampsie kann die Entstehung von C5b-9 Komplementkomplex beteiligt sein.
Abstract
We describe a patient with severe preeclampsia and postpartum complications in whom we investigated a panel of autoimmune reactions.
Case Report
A 27-year-old primigravida was referred at 37 weeks' gestation because of severe preeclampsia. A cesarean section was performed. Postpartum the patient developed severe cardiac dysfunction, thrombocytopenia, eclamptic seizures, and blindness. Immunohistochemical studies of the placenta showed marked deposition of terminal C5b-9 complement complex in intervillous fibrin and in intravillous stroma.
Conclusion
The generation of C5b-9 complement complex may be involved in the pathogenesis of preeclampsia-eclampsia.
Schlüsselwörter
Präeklampsie - Antiphospholipidsyndrom - β2-GPI-Antikörper - Komplementkomplex C5b-9
Key words
Preeclampsia - Antiphospholipid syndrome - β2-GPI antibodies - Complement complex C5 b-9
References
- 1 Kaunitz A M, Hughes M J, Grimes D A, Smith J C, Rochat R W, Kafrissen M E. Causes of maternal mortality in the United States. Obstet Gynecol. 1985; 65 605-612
- 2 Sibai B M. Preeclampsia-eclampsia. Curr Prob Obstet Gynecol Fertil. 1990; 13 1-45
-
3 Sibai B M.
Chronic hypertension during pregnancy. Sciarra J Gynecology and Obstetrics. Philadelphia; JB Lippincott 1989: 1-8 - 4 Long P A, Oats J N. Preeclampsia in twin pregnancy - severity and pathogenesis. Austr N Z J Obstet Gynaecol. 1987; 27 1-5
- 5 Harris E N. Syndrome of the black swan. Br J Rheumatol. 1987; 26 324
- 6 Lockwood C J, Romero R, Feinberg R F, Clyne L P, Costwer B, Hobbins J C. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol. 1989; 161 369
- 7 MacLean M A, Cumming G P, McCall F, Walker I D, Walker J J. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriage. Br J Obstet Gynaecol. 1994; 101 103
- 8 Harris E N. A reassessment of the antiphospholipid syndrome. J Rheumatol. 1990; 17 733-735
- 9 Branch D W, Scott J R, Kochenour N K. et al . Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 1985; 313 1322-1326
- 10 Branch D W, Andres R, Digre K B, Rote N S, Scott J R. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol. 1989; 73 541-545
- 11 Kochenour N K, Branch D W, Rote N S, Scott J R. A new postpartum syndrome associated with antiphospholipid antibodies. Obstet Gynecol. 1987; 69 460-468
- 12 Yamamoto T, Yoshimura S, Geshi Y, Sasamori S. et al . Measurement of antiphospholipid antibody by ELISA using purified β2-glycoprotein I in preeclampsia. Clin Exp Immunol. 1993; 94 196-200
- 13 Scott R AH. Anticardiolipin antibodies and preeclampsia. Br J Obstet Gynaecol. 1987; 94 604-605
- 14 Lynch A, Byers T, Emlen W. et al . Association of antibodies to β2-glycoprotein I with pregnancy loss and pregnancy-induced hypertension: A prospective study in low-risk pregnancy. Obstet Gynecol. 1999; 93 193-198
- 15 Galli M, Comfurius P, Barbui T, Zwaal R F, Bevers E M. Anticoagulant activity of beta-2-glycoprotein-I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost. 1992; 68 297-300
- 16 Thiagarajan P, Pengo V, Shapiro S S. The use of dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood. 1986; 68 869
- 17 Harris E N, Gharavi A E, Patel S P, Hughes G RV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4th April 1986. Clin Exp Immunol. 1987; 68 215
- 18 Granger K A, Farquharson R G. Obstetric outcome in antiphospholipid syndrome. Lupus. 1997; 6 509
- 19 Furlan M, Robles R, Galbusera M. et al . Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med. 1998; 339 1578-1584
-
20 DeSwiet M.
The cardiovascular system. Hytten FE, Chamberlain GVP Clinical Physiology in Obstetrics. Oxford; Blackwell Scientific Publications 1980: 3-42 - 21 Clark S L, Cotton D B, Lee W. et al . Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol. 1989; 161 1439-1442
- 22 Cotton D B, Lee W, Huhta J C. Dorman KF. Hemodynamic profile of severe pregnancy-induced hypertension. Am J Obstet Gynecol. 1988; 158 523-529
- 23 Groenendijk R, Trimbos J BMJ, Wallenburg H CS. Hemodynamic measurements in preeclampsia: preliminary observations. Am J Obstet Gynecol. 1984; 150 232-236
- 24 Kirshon B, Cotton D B. Invasive hemodynamic monitoring in the obstetric patient. Clin Obstet Gynecol. 1987; 30 579-590
- 25 Abdul-Karim R, Assali N S. Pressor response to angiotensin in pregnant and non-pregnant women. Am J Obstet Gynecol. 1961; 82 246-251
- 26 Gant N F, Daley G L, Chand S, Whalley J P, MacDonald P C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973; 52 2682-2689
- 27 Pollak V E, Nettles J B. The kidney in toxemia of pregnancy: a clinical and pathologic study based on renal biopsies. Medicine. 1960; 39 469-526
- 28 Brown C EL, Purdy P, Cunnigham F G. Head computed tomographic scans in women with eclampsia. Am J Obstet Gynecol. 1988; 59 915-920
- 29 Volz-Köster S, Frühauf J, Gaa J, Volz J. Cerebral manifestation of eclampsia. Geburtsh Frauenheilk. 2001; 61 153-155
- 30 Heilmann L, Schneider D M, Tempelhoff G-F, Kuse S. Antiphospholipid-Antikörper und andere hämostaseologische Veränderungen bei Patientinnen mit früher schwerer Präeklampsie oder HELLP-Syndrom in der Anamnese. Geburtsh Frauenheilk. 2000; 60 95
- 31 Hed J. Role of complement in immune or idiopathic thrombocytopenic purpura. Acta Paediatr Suppl. 1988; 424 37-40
- 32 Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol. 1996; 93 1-5
- 33 Egarter C, Hundegger R, Husslein P, Topcuoglu A, Kyrle A. Postpartale Blutungen und von Willebrand-Jürgens-Syndrom. Geburtsh Frauenheilk. 2000; 60 523
- 34 Weiner C P. Thrombotic microangiopathy in pregnancy and the postpartum period. Semin Hematol. 1987; 24 119-129
- 35 Schäfer H J, Mathey D, Hugo F, Bhakdi S. Deposition of the terminal C5 b-9 complement complex in infarcted areas of human myocardium. J Immunol. 1986; 137 1945-1949
- 36 Rath W. Disseminierte intravasale Gerinnung (DIG) - Verbrauchskoagulopathie. Geburtsh Frauenheilk. 2001; 61 37-40
- 37 Fernandez H N, Henson P M, Otani A, Hugli T E. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated conditions. J Immunol. 1978; 120 109
- 38 Bhakdi S, Tranum-Jensen J. Molecular weight of the membrane C5 b-9 complex of human complement: characterization of the terminal complex as a C5 b-9 monomer. Proc Natl Acad Sci USA. 1981; 78 1818
MD DSc Taufik Hamdosch
Abt. Innere Medizin
Kreiskrankenhaus Aurich
Wallinghauser Str. 12
26603 Aurich